查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
基因分型市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按产品类型、技术、应用、最终用户和地理位置
市场调查报告书
商品编码
1558399

基因分型市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按产品类型、技术、应用、最终用户和地理位置

Genotyping Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Technology, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 250 Pages | 订单完成后即时交付

价格

根据我们关于「到 2031 年基因分型市场预测 - 全球分析 - 按产品类型、技术、应用、最终用户和地理位置」的新研究，该市场预计将从 2023 年的 304.4 亿美元增长到2031年达到1543.5亿美元；预计 2023-2031 年复合年增长率为 22.5%。用于诊断遗传和罕见疾病、生物技术和製药行业的技术进步和研发投资的增加是促进基因分型市场成长的因素。然而，设备成本高昂和熟练专业人员的短缺阻碍了市场的成长。此外，个人化医疗的日益普及预计将在未来几年带来新的基因分型市场趋势。

基因分型是製药业最有前景的途径之一，为治疗各种疾病和医疗状况提供了独特的方法。由于製药和生技公司投入大量资金改善其生产设施，基因分型市场不断成长。慢性病病例和诊断数量的增加需要复杂的诊断和治疗药物的可用性，这推动了全球基因分型市场的发展。此外，不断增长的需求、对创新疗法的更高接受度以及不断增加的临床试验预计将推动市场成长。然而，生物相似药的批准是限制基因分型市场扩张的主要方面之一。

2023年，北美占据全球基因分型市场的主要份额。越来越多地采用技术先进的产品和解决方案，以及激增的研发活动是有利于该地区基因分型市场的因素。此外，政府主导的计画（例如「我们所有人研究计画」）、各个基因组社区的倡议以及对基因分型服务的认识不断提高是整个北美市场扩张的关键驱动力。

由美国国立卫生研究院 (NIH) 领导的正在进行的「我们所有人研究计划」提供了 2860 万美元的资金，用于在美国建立三个基因组中心。该研究计画旨在透过美国不同机构的基因分型服务加速精准医学的发现。同样，启动了「我的生活，我们的未来」项目，对血友病患者进行基因分型，并建立一个生物样本库作为未来的研究资源。此外，医疗保健支出的快速增长反映出遗传疾病和癌症的新诊断工具的可用性不断增加。蓬勃发展的製药和生物製药产业为美国基因分型市场创造了有利的环境。该国的市场参与者已为其创新註册了各种专利。

各国政府和私营农业协会高度关注作物基因组学的进步，以改善作物的特性。国家粮食和农业研究所的农业基因组到表型组计划（AG2PI）侧重于合作，发展研究作物和动物遗传学的研究人员社区，这将为扩展关于基因组和表型组的知识奠定基础，这对于农业和农业至关重要。该倡议可能会导致开发出一些方法来了解多变的天气、环境和生产系统如何影响农作物和动物的遗传多样性。因此，越来越多的措施促进与农作物基因组成相关的研究，以提高产量和质量，未来可能有利于美国的基因分型市场。

扩大应用范围，为未来提供市场机会

基因分型在诊断研究、药物基因体学和农业生物技术中具有潜在的应用。此外，该技术适用于各种植物育种、法医和环境测试程序。製药公司受益于多基因风险评分、与患者健康资讯相关的大量基因资料库以及临床试验参与者的定序资料等进步。产业药物基因组学工作小组 (I-PWG) 是一个製药公司协会，积极参与药物基因组学研究。 I-PWG 由 26 家成员公司组成，每年进行大量临床试验，收集研究对象的 DNA 样本作为协议的一部分。 I-PWG 专注于临床药物基因组学，旨在在未来几年为製药公司创造机会。除了最常用于肿瘤学研究之外，它还用于非肿瘤治疗领域（例如罕见疾病、免疫学和心臟病学）进行的 PGx 研究。一项更全面的研究，涉及临床试验样本的 NGS，可以对试验参与者进行详细的基因组评估，揭示常见和罕见的遗传变异。 PGx 包括在确定基因组层级药物/异生素效应、药物反应和疾病易感性以及基因型/表型关係方面的多态性差异研究。

定序基因分型（GBS）是一种利用NGS方法对作物基因组和人类基因组中的SNP进行定位和基因分型的新方法。 GBS 被开发并部署在多个样本的定序中，透过在此过程中加入分子标记，进一步增强 NGS 在玉米和小麦等巨型作物基因组定序中的应用。 GBS检测的高通量SNP广泛应用于许多植物物种的遗传多样性分析、全基因组关联研究(GWAS)、QTL定位和基因组预测(GP)。 NGS技术以高通量和低成本改变了现代生物学。随着 NGS 技术的显着进步，全基因组定序提供了超高通量序列，彻底改变了植物基因分型和育种。边合成边定序（SBS）和多重定序大大提高了定序效率。

因此，在各个研究领域中更多地采用基因分型最终将导致对这些技术的需求增加，从而在市场上创造重大机会。

基因分型市场：竞争格局与主要发展

F. Hoffmann-La Roche Ltd.、Integrated DNA Technologies, Inc. (Danaher)、Qiagen、Merck KGaA、Eurofins Genomics、Thermo Fisher Scientific Inc.、BioTek Instruments, Inc.、Xcelris Genomics、Trimgen Corporation 和 Illumina, Inc.基因分型市场上的主要公司之一。

美国食品药物管理局、疾病管制与预防中心 (CDC) 以及经济合作暨发展组织是准备基因分型市场报告时参考的主要和次要来源。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：基因分型市场格局

  • 概述
  • PEST分析
  • 全球市占率分析
    • NGS 文库製备领先厂商的全球市占率 (%)
    • 基因分型领先厂商的全球市占率 (%)
    • 基因表现领域领导企业的全球市场占有率 (%)

第 5 章：基因分型市场 - 主要市场动态

  • 基因分型市场 - 主要市场动态
  • 市场驱动因素：
    • 用于诊断遗传疾病和罕见疾病
    • 生物技术和製药行业的技术进步和研发投资的增加
  • 市场限制
    • 设备成本高，技术人员短缺
  • 市场机会
    • 扩大应用范围
  • 未来趋势
    • 个人化医疗越来越受欢迎
  • 驱动因素和限制的影响：

第 6 章：基因分型市场 - 全球市场分析

  • 基因分型市场收入，2021-2031

第 7 章：基因分型市场分析 - 依产品类型

  • 仪器仪表
  • 试剂和试剂盒
  • 生物资讯学
  • 基因分型服务

第 8 章：基因分型市场分析 - 依技术

  • 微阵列
  • 毛细管电泳
  • 定序
  • 聚合酶炼式反应 (PCR)
  • 基质辅助雷射解吸/MALDI-TOF
  • 其他技术

第 9 章：基因分型市场分析 - 按应用

  • 药物基因组学
  • 诊断及个人化医疗
  • 动物遗传学
  • 农业生物技术
  • 其他应用

第 10 章：基因分型市场分析 - 依最终用户

  • 製药和生物製药公司
  • 诊断与研究实验室
  • 学术机构
  • 其他最终用户

第 11 章：基因分型市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区

第 12 章：产业格局

  • 概述
  • 基因分型市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • Hoffmann-La Roche Ltd
  • QIAGEN NV
  • Merck KGaA
  • EUROFINS GENOMICS
  • Thermo Fisher Scientific Inc
  • BioTek Instruments, Inc.
  • XCELRIS GENOMICS
  • TRIMGEN CORPORATION
  • Illumina Inc
  • Danaher Corp
  • Bio-Rad Laboratories Inc
  • GE HealthCare Technologies Inc
  • Standard BioTools Inc
  • Laboratory Corp of America Holdings
  • Beckman Coulter Inc
  • BGI
  • Takara Bio Inc
  • DiaSorin SpA

第 14 章：附录

Product Code: TIPHE100001166

According to our new research study on "Genotyping Market Forecast to 2031 - Global Analysis - by Product Type, Technology, Application, End User, and Geography," the market is anticipated to grow from US$ 30.44 billion in 2023 and is projected to reach US$ 154.35 billion by 2031; it is expected to register a CAGR of 22.5% during 2023-2031. Use in the diagnosis of genetic and rare diseases, and technological advancements and rising R&D investments in the biotechnology and pharmaceutical industries are among the factors contributing to genotyping market growth. However, the high cost of equipment and shortage of skilled professionals hamper the market growth. Further, the increasing popularity of personalized medicine is expected to bring new genotyping market trends in the coming years.

Genotyping are among the most promising avenues in the pharmaceutical industry, offering a unique approach to treating various diseases and medical conditions. The genotyping market is constantly growing because pharma and biotechnology companies enormously invest in improving their production facilities. The increasing number of cases and diagnoses of chronic diseases requires the availability of sophisticated diagnostic and treatment drugs, which has boosted the global genotyping market. Furthermore, rising demand, higher acceptance of innovative therapies, and increasing clinical trials are expected to drive market growth. However, approving biosimilars is one of the main aspects limiting the genotyping market expansion.

North America accounted for a major share of the global genotyping market in 2023. The North America genotyping market is segmented into the US, Canada, and Mexico. Increasing adoption of technologically advanced products and solutions, and surging research and development activities are the factors benefiting the genotyping market in this region. Moreover, government-led programs such as the "All of Us Research Program," initiatives by various genomic communities, and the increasing awareness of genotyping services are the key drivers of the market expansion across North America.

The ongoing "All of Us Research Program" led by the National Institutes of Health (NIH) provided US$ 28.6 million in funding to develop three genome centers across the US. This research program aims to accelerate precision medicine discoveries through genotyping services in different institutions in the US. Similarly, the "My Life, Our Future" project was initiated to carry out genotyping of hemophilia patients and to build a biorepository as a research resource for the future. Further, a rapid surge in healthcare expenditure reflects the increasing availability of new diagnostic tools for genetic diseases and cancer. The flourishing pharmaceutical and biopharmaceutical industry creates a conducive environment for the genotyping market in the US. Market players in this country have registered various patents for their innovations.

Governments and private agricultural associations are highly focused on advancements in crop genomics to improve the characteristics of crops. The Agricultural Genome to Phenome Initiative (AG2PI) of the National Institute of Food and Agriculture focuses on collaborative engagements to develop a community of researchers studying both crop and animal genetics, which would lay the foundation for expanding knowledge about genomes and phenomes that are important to the agriculture sector in the US. The initiative is likely to result in the development of approaches to understanding how variable weather, environments, and production systems impact genetic diversity in crops and animals. Thus, the rising number of initiatives taken to foster studies related to the genetic makeup of crops for yield and quality improvement are likely to favor the genotyping market in the US in the future.

Expanding Range of Applications to Provide Market Opportunities in Future

Genotyping holds potential applications in diagnostic research, pharmacogenomics, and agricultural biotechnology. Moreover, this technique is suitable for a variety of plant breeding, forensic, and environmental testing procedures. Pharmaceutical companies are profiting from the availability of polygenic risk scores, substantial genetic databases linked to patient health information, and the sequencing data of clinical trial participants, among other advancements. The Industry Pharmacogenomics Working Group (I-PWG), an association of pharmaceutical companies, is actively involved in pharmacogenomic research. The I-PWG comprises 26 member companies that undertake numerous clinical trials annually, collecting DNA samples of study subjects as part of the protocol. With its focus on clinical pharmacogenomics, the I-PWG aims to generate opportunities for pharmaceutical companies in the coming years. In addition to its most frequent use in oncology research, it is also used for PGx studies conducted in non-oncology therapeutic areas such as rare diseases, immunology, and cardiology. A more comprehensive study, involving the NGS of clinical trial samples, allows for an elaborate genomic evaluation of trial participants, revealing both common and rare genetic variations. PGx includes the study of polymorphic differences in the determination of genomic-level drug/xenobiotic effects, drug response and disease susceptibility, and genotype/phenotype relationships.

Genotyping-by-sequencing (GBS) is a new method to locate and genotype SNPs in crop genomes and human genome by using NGS methods. GBS is developed and deployed in sequencing multiple samples by incorporating molecular markers in the process to further enhance NGS applications in giant crop genome sequencing, such as maize and wheat. High-throughput SNPs detected by GBS are widely used in genetic diversity analysis, genome-wide association studies (GWAS), QTL mapping, and genome prediction (GP) in many plant species. NGS technology has transformed modern biology with high throughput and low cost. With remarkable advancements unlocked by NGS technologies, whole-genome sequencing provides ultra-throughput sequences that revolutionize plant genotyping and breeding. Sequencing by synthesis (SBS) and multiplexing greatly enhance the efficiency of the sequence.

Therefore, greater adoption of genotyping in various research areas would eventually lead to a rise in the demand for these techniques, creating significant opportunities in the market.

Genotyping Market: Competitive Landscape and Key Developments

F. Hoffmann-La Roche Ltd., Integrated DNA Technologies, Inc. (Danaher), Qiagen, Merck KGaA, Eurofins Genomics, Thermo Fisher Scientific Inc., BioTek Instruments, Inc., Xcelris Genomics, Trimgen Corporation, and Illumina, Inc. are among the key companies operating in the genotyping market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Organisation for Economic Co-operation and Development are among the primary and secondary sources referred to while preparing the genotyping market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Genotyping Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Global Market Share Analysis
    • 4.3.1 Global Market Share (%) of Leading Players for NGS Library Preparation
    • 4.3.2 Global Market Share (%) of Leading Player for Genotyping
    • 4.3.3 Global Market Share (%) of Leading Player for Gene Expression

5. Genotyping Market - Key Market Dynamics

  • 5.1 Genotyping Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Use in Diagnosis of Genetic and Rare Diseases
    • 5.2.2 Technological Advancements and Rising R&D Investments in Biotechnology and Pharmaceutical Industry
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Equipment and Shortage of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Expanding Range of Applications
  • 5.5 Future Trends
    • 5.5.1 Increasing Popularity of Personalized Medicine
  • 5.6 Impact of Drivers and Restraints:

6. Genotyping Market - Global Market Analysis

  • 6.1 Genotyping Market Revenue (US$ Million), 2021-2031

7. Genotyping Market Analysis - by Product Type

  • 7.1 Instruments
    • 7.1.1 Overview
    • 7.1.2 Instruments: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Reagents and Kits
    • 7.2.1 Overview
    • 7.2.2 Reagents and Kits: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Bioinformatics
    • 7.3.1 Overview
    • 7.3.2 Bioinformatics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Genotyping Services
    • 7.4.1 Overview
    • 7.4.2 Genotyping Services: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

8. Genotyping Market Analysis - by Technology

  • 8.1 Microarray
    • 8.1.1 Overview
    • 8.1.2 Microarray: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Capillary Electrophoresis
    • 8.2.1 Overview
    • 8.2.2 Capillary Electrophoresis: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Sequencing
    • 8.3.1 Overview
    • 8.3.2 Sequencing: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Polymerase Chain Reaction (PCR)
    • 8.4.1 Overview
    • 8.4.2 Polymerase Chain Reaction (PCR): Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Matrix-Assisted Laser Desorption / MALDI-TOF
    • 8.5.1 Overview
    • 8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Other Technologies
    • 8.6.1 Overview
    • 8.6.2 Other Technologies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

9. Genotyping Market Analysis - by Application

  • 9.1 Pharmacogenomics
    • 9.1.1 Overview
    • 9.1.2 Pharmacogenomics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Diagnostics and Personalized Medicine
    • 9.2.1 Overview
    • 9.2.2 Diagnostics and Personalized Medicine: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Animal Genetics
    • 9.3.1 Overview
    • 9.3.2 Animal Genetics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Agricultural Biotechnology
    • 9.4.1 Overview
    • 9.4.2 Agricultural Biotechnology: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Other Applications
    • 9.5.1 Overview
    • 9.5.2 Other Applications: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

10. Genotyping Market Analysis - by End-user

  • 10.1 Pharmaceutical and Biopharmaceutical Companies
    • 10.1.1 Overview
    • 10.1.2 Pharmaceutical and Biopharmaceutical Companies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Diagnostic and Research Laboratories
    • 10.2.1 Overview
    • 10.2.2 Diagnostic and Research Laboratories: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Academic Institutes
    • 10.3.1 Overview
    • 10.3.2 Academic Institutes: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Other End Users
    • 10.4.1 Overview
    • 10.4.2 Other End Users: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

11. Genotyping Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Genotyping Market Overview
    • 11.2.2 North America: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
      • 11.2.2.1 North America: Genotyping Market - Revenue and Forecast Analysis - by Product Type
      • 11.2.2.2 North America: Genotyping Market - Revenue and Forecast Analysis - by Technology
      • 11.2.2.3 North America: Genotyping Market - Revenue and Forecast Analysis - by Application
      • 11.2.2.4 North America: Genotyping Market - Revenue and Forecast Analysis - by End-user
    • 11.2.3 North America: Genotyping Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 United States: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.3.1.1 United States: Genotyping Market Breakdown, by Product Type
        • 11.2.3.1.2 United States: Genotyping Market Breakdown, by Technology
        • 11.2.3.1.3 United States: Genotyping Market Breakdown, by Application
        • 11.2.3.1.4 United States: Genotyping Market Breakdown, by End-user
      • 11.2.3.2 Canada: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.3.2.1 Canada: Genotyping Market Breakdown, by Product Type
        • 11.2.3.2.2 Canada: Genotyping Market Breakdown, by Technology
        • 11.2.3.2.3 Canada: Genotyping Market Breakdown, by Application
        • 11.2.3.2.4 Canada: Genotyping Market Breakdown, by End-user
      • 11.2.3.3 Mexico: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.3.3.1 Mexico: Genotyping Market Breakdown, by Product Type
        • 11.2.3.3.2 Mexico: Genotyping Market Breakdown, by Technology
        • 11.2.3.3.3 Mexico: Genotyping Market Breakdown, by Application
        • 11.2.3.3.4 Mexico: Genotyping Market Breakdown, by End-user
  • 11.3 Europe
    • 11.3.1 Europe Genotyping Market Overview
    • 11.3.2 Europe: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
      • 11.3.2.1 Europe: Genotyping Market - Revenue and Forecast Analysis - by Product Type
      • 11.3.2.2 Europe: Genotyping Market - Revenue and Forecast Analysis - by Technology
      • 11.3.2.3 Europe: Genotyping Market - Revenue and Forecast Analysis - by Application
      • 11.3.2.4 Europe: Genotyping Market - Revenue and Forecast Analysis - by End-user
    • 11.3.3 Europe: Genotyping Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 United Kingdom: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.1.1 United Kingdom: Genotyping Market Breakdown, by Product Type
        • 11.3.3.1.2 United Kingdom: Genotyping Market Breakdown, by Technology
        • 11.3.3.1.3 United Kingdom: Genotyping Market Breakdown, by Application
        • 11.3.3.1.4 United Kingdom: Genotyping Market Breakdown, by End-user
      • 11.3.3.2 Germany: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.2.1 Germany: Genotyping Market Breakdown, by Product Type
        • 11.3.3.2.2 Germany: Genotyping Market Breakdown, by Technology
        • 11.3.3.2.3 Germany: Genotyping Market Breakdown, by Application
        • 11.3.3.2.4 Germany: Genotyping Market Breakdown, by End-user
      • 11.3.3.3 France: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.3.1 France: Genotyping Market Breakdown, by Product Type
        • 11.3.3.3.2 France: Genotyping Market Breakdown, by Technology
        • 11.3.3.3.3 France: Genotyping Market Breakdown, by Application
        • 11.3.3.3.4 France: Genotyping Market Breakdown, by End-user
      • 11.3.3.4 Spain: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.4.1 Spain: Genotyping Market Breakdown, by Product Type
        • 11.3.3.4.2 Spain: Genotyping Market Breakdown, by Technology
        • 11.3.3.4.3 Spain: Genotyping Market Breakdown, by Application
        • 11.3.3.4.4 Spain: Genotyping Market Breakdown, by End-user
      • 11.3.3.5 Italy: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.5.1 Italy: Genotyping Market Breakdown, by Product Type
        • 11.3.3.5.2 Italy: Genotyping Market Breakdown, by Technology
        • 11.3.3.5.3 Italy: Genotyping Market Breakdown, by Application
        • 11.3.3.5.4 Italy: Genotyping Market Breakdown, by End-user
      • 11.3.3.6 Rest of Europe: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.6.1 Rest of Europe: Genotyping Market Breakdown, by Product Type
        • 11.3.3.6.2 Rest of Europe: Genotyping Market Breakdown, by Technology
        • 11.3.3.6.3 Rest of Europe: Genotyping Market Breakdown, by Application
        • 11.3.3.6.4 Rest of Europe: Genotyping Market Breakdown, by End-user
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Genotyping Market Overview
    • 11.4.2 Asia Pacific: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
      • 11.4.2.1 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by Product Type
      • 11.4.2.2 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by Technology
      • 11.4.2.3 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by Application
      • 11.4.2.4 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by End-user
    • 11.4.3 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 China: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.1.1 China: Genotyping Market Breakdown, by Product Type
        • 11.4.3.1.2 China: Genotyping Market Breakdown, by Technology
        • 11.4.3.1.3 China: Genotyping Market Breakdown, by Application
        • 11.4.3.1.4 China: Genotyping Market Breakdown, by End-user
      • 11.4.3.2 Japan: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.2.1 Japan: Genotyping Market Breakdown, by Product Type
        • 11.4.3.2.2 Japan: Genotyping Market Breakdown, by Technology
        • 11.4.3.2.3 Japan: Genotyping Market Breakdown, by Application
        • 11.4.3.2.4 Japan: Genotyping Market Breakdown, by End-user
      • 11.4.3.3 India: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.3.1 India: Genotyping Market Breakdown, by Product Type
        • 11.4.3.3.2 India: Genotyping Market Breakdown, by Technology
        • 11.4.3.3.3 India: Genotyping Market Breakdown, by Application
        • 11.4.3.3.4 India: Genotyping Market Breakdown, by End-user
      • 11.4.3.4 Australia: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.4.1 Australia: Genotyping Market Breakdown, by Product Type
        • 11.4.3.4.2 Australia: Genotyping Market Breakdown, by Technology
        • 11.4.3.4.3 Australia: Genotyping Market Breakdown, by Application
        • 11.4.3.4.4 Australia: Genotyping Market Breakdown, by End-user
      • 11.4.3.5 South Korea: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.5.1 South Korea: Genotyping Market Breakdown, by Product Type
        • 11.4.3.5.2 South Korea: Genotyping Market Breakdown, by Technology
        • 11.4.3.5.3 South Korea: Genotyping Market Breakdown, by Application
        • 11.4.3.5.4 South Korea: Genotyping Market Breakdown, by End-user
      • 11.4.3.6 Rest of APAC: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.6.1 Rest of APAC: Genotyping Market Breakdown, by Product Type
        • 11.4.3.6.2 Rest of APAC: Genotyping Market Breakdown, by Technology
        • 11.4.3.6.3 Rest of APAC: Genotyping Market Breakdown, by Application
        • 11.4.3.6.4 Rest of APAC: Genotyping Market Breakdown, by End-user
  • 11.5 Middle East and Africa
    • 11.5.1 Middle East and Africa Genotyping Market Overview
    • 11.5.2 Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
      • 11.5.2.1 Middle East and Africa: Genotyping Market - Revenue and Forecast Analysis - by Product Type
      • 11.5.2.2 Middle East and Africa: Genotyping Market - Revenue and Forecast Analysis - by Technology
      • 11.5.2.3 Middle East and Africa: Genotyping Market - Revenue and Forecast Analysis - by Application
      • 11.5.2.4 Middle East and Africa: Genotyping Market - Revenue and Forecast Analysis - by End-user
    • 11.5.3 Middle East and Africa: Genotyping Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.1.1 Saudi Arabia: Genotyping Market Breakdown, by Product Type
        • 11.5.3.1.2 Saudi Arabia: Genotyping Market Breakdown, by Technology
        • 11.5.3.1.3 Saudi Arabia: Genotyping Market Breakdown, by Application
        • 11.5.3.1.4 Saudi Arabia: Genotyping Market Breakdown, by End-user
      • 11.5.3.2 South Africa: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.2.1 South Africa: Genotyping Market Breakdown, by Product Type
        • 11.5.3.2.2 South Africa: Genotyping Market Breakdown, by Technology
        • 11.5.3.2.3 South Africa: Genotyping Market Breakdown, by Application
        • 11.5.3.2.4 South Africa: Genotyping Market Breakdown, by End-user
      • 11.5.3.3 United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.3.1 United Arab Emirates: Genotyping Market Breakdown, by Product Type
        • 11.5.3.3.2 United Arab Emirates: Genotyping Market Breakdown, by Technology
        • 11.5.3.3.3 United Arab Emirates: Genotyping Market Breakdown, by Application
        • 11.5.3.3.4 United Arab Emirates: Genotyping Market Breakdown, by End-user
      • 11.5.3.4 Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.4.1 Rest of Middle East and Africa: Genotyping Market Breakdown, by Product Type
        • 11.5.3.4.2 Rest of Middle East and Africa: Genotyping Market Breakdown, by Technology
        • 11.5.3.4.3 Rest of Middle East and Africa: Genotyping Market Breakdown, by Application
        • 11.5.3.4.4 Rest of Middle East and Africa: Genotyping Market Breakdown, by End-user

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Genotyping Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 QIAGEN NV
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Merck KGaA
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 EUROFINS GENOMICS
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Thermo Fisher Scientific Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 BioTek Instruments, Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 XCELRIS GENOMICS
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 TRIMGEN CORPORATION
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Illumina Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Danaher Corp
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Rad Laboratories Inc
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 GE HealthCare Technologies Inc
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Standard BioTools Inc
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Laboratory Corp of America Holdings
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Beckman Coulter Inc
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 BGI
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Takara Bio Inc
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 DiaSorin SpA
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Genotyping Market Segmentation
  • Table 2. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 3. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 4. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by End-user
  • Table 6. North America: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 7. North America: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 8. North America: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 9. North America: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 10. United States: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 11. United States: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 12. United States: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 13. United States: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 14. Canada: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 15. Canada: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 16. Canada: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 17. Canada: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 18. Mexico: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 19. Mexico: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 20. Mexico: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 21. Mexico: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 22. Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 23. Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 24. Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 25. Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 26. United Kingdom: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 27. United Kingdom: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 28. United Kingdom: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 29. United Kingdom: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 30. Germany: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 31. Germany: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 32. Germany: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 33. Germany: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 34. France: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 35. France: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 36. France: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 37. France: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 38. Spain: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 39. Spain: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 40. Spain: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 41. Spain: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 42. Italy: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 43. Italy: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 44. Italy: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 45. Italy: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 46. Rest of Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 47. Rest of Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 48. Rest of Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 49. Rest of Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 50. Asia Pacific: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 51. Asia Pacific: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 52. Asia Pacific: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 53. Asia Pacific: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 54. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 55. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 56. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 57. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 58. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 59. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 60. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 61. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 62. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 63. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 64. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 65. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 66. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 67. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 68. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 69. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 70. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 71. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 72. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 73. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 74. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 75. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 76. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 77. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 78. Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 79. Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 80. Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 81. Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 82. Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 83. Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 84. Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 85. Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 86. South Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 87. South Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 88. South Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 89. South Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 90. United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 91. United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 92. United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 93. United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 94. Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 95. Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 96. Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 97. Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 98. Recent Organic Growth Strategies in Genotyping Market
  • Table 99. Recent Inorganic Growth Strategies in the Genotyping Market
  • Table 100. Glossary of Terms, Genotyping Market

List Of Figures

  • Figure 1. Genotyping Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Genotyping Market Revenue (US$ Million), 2021-2031
  • Figure 5. Genotyping Market Share (%) - by Product Type (2023 and 2031)
  • Figure 6. Instruments: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Reagents and Kits: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Bioinformatics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Genotyping Services: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Genotyping Market Share (%) - by Technology (2023 and 2031)
  • Figure 11. Microarray: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Capillary Electrophoresis: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Sequencing: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Polymerase Chain Reaction (PCR): Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Other Technologies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Genotyping Market Share (%) - by Application (2023 and 2031)
  • Figure 18. Pharmacogenomics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Diagnostics and Personalized Medicine: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Animal Genetics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Agricultural Biotechnology: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Other Applications: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Genotyping Market Share (%) - by End-user (2023 and 2031)
  • Figure 24. Pharmaceutical and Biopharmaceutical Companies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Diagnostic and Research Laboratories: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Academic Institutes: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Other End Users: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Genotyping Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 29. North America: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. North America: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 31. United States: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Canada: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Mexico: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. Europe: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 36. United Kingdom: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. Germany: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. France: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 39. Spain: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. Italy: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Rest of Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Asia Pacific: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. Asia Pacific: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 44. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 48. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 49. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 50. Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 51. Middle East and Africa: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 52. Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 53. South Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 55. Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 56. Growth Strategies in Genotyping Market